
Managing Your Life Sciences Portfolio: False Claims Act Risk for Private Investors and How AdvaMed Can Help
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed developed tools and resources to…